FDA OKs Postnatal Blood Test for Intellectual Disabilities

From Medscape (1/17/14):

FDA OKs Postnatal Blood Test for Intellectual Disabilities

The US Food and Drug Administration (FDA) has cleared for marketing the CytoScan Dx Assay (Affymetrix), which detects chromosomal variations that may underlie a child's developmental delay or intellectual disability.

http://www.medscape.com/viewarticle/819387